Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma

Figure 5

Targeting AKT/mTOR had a therapeutic significance on ALK + tumor cells. (A) Synergistic growth inhibition between the dual PI3K/mTOR inhibitor, NVP-BEZ235, and Dex in all cells, especially in BaF3/NPM-ALK. (B) A higher apoptosis rate in cells treated with NVP-BEZ235 and Dex together compared with single use of the drugs.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us